Stanley Lewis on Lytic Peptides - The Ultimate Cancer Weapon

Full Episode – Innovating Tomorrow’s Medicine ft. Dr. Stanley Lewis, CEO of A28 Therapeutics.

Dr. Stanley Lewis shares a glimpse into how A28 Therapeutics is transforming the field of cancer using lytic peptides as a novel payload.

➡️ Full episode launches on 28 August

🔔 Subscribe and hit the bell so you don’t miss it!

🎙️ About the Show: Innovating Tomorrow’s Medicine features bold conversations with pioneers shaping the future of healthcare, biotechnology, and life sciences.

📌 Stay tuned for the full interview where we explore and share unique insights:

– The vision behind A28 Therapeutics

– Next-generation payload for cancer therapy

– Role of AI and machine learning in R&D

– Fund raising

– Leadership and culture

– Personal reflections and future outlook

#SneakPeek #StanleyLewis #A28Therapeutics #Biotech #Cancer #FutureOfMedicine